Description
This product contains two synthetic peptides in a single lyophilized preparation.
CJC-1295 without DAC, also designated Modified GRF (1-29), is a 29-residue analogue of the N-terminal fragment of growth hormone-releasing hormone (GHRH 1-29). It carries four amino acid substitutions relative to the native fragment, which reduce susceptibility to enzymatic cleavage, and a C-terminal amide. It does not carry the Drug Affinity Complex linker found in the DAC version.
Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH₂, containing the unnatural residues alpha-aminoisobutyric acid and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide. In published literature it has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), distinguished within its class by reported selectivity for that receptor.
This material is supplied as a characterized reference preparation for non-clinical laboratory work, such as analytical method development and separation of multi-peptide preparations, GHRH receptor and GHS-R1a binding assays, comparative receptor selectivity profiling, and somatotroph cell culture assays.
Compound Specifications
| Property | CJC-1295 (no DAC) | Ipamorelin |
|---|---|---|
| Other designations | Modified GRF (1-29), Mod GRF 1-29 | — |
| Sequence length | 29 residues | 5 residues |
| Sequence | [supply from COA] | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Molecular formula | [see note below] | C₃₈H₄₉N₉O₅ |
| Molecular weight | ~3368 g/mol [verify] | ~711.9 g/mol |
| CAS number | 863288-34-0 [see note] | 170851-70-4 |
Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.
FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

